Press release
Respiratory Inhalers Market Top Companies Study - GlaxoSmithKline, Novartis, Boehringer Ingelheim, Cipla, AstraZeneca.
Respiratory Inhalers Market
According to the latest research by Insight Analytics, the global Respiratory Inhalers market was valued at USD 33.6 Billion in 2024. It is expected to reach USD 59.7 Billion by the year 2034, with a CAGR of 6.0 % during a forecast period of 2025-2034.
Get Free Access to Demo Report, Excel Pivot and ToC: https://www.insightaceanalytic.com/request-sample/1288
In recent years, the incidence of respiratory disorders has increased significantly, largely influenced by factors such as tobacco use, industrial emissions, environmental pollution, and the emergence of new pulmonary conditions. Respiratory inhalers have emerged as essential therapeutic tools, facilitating targeted drug delivery to the lungs for the treatment and management of chronic respiratory diseases. The market offers a wide spectrum of delivery systems, including dry powder inhalers (DPIs), metered-dose inhalers (MDIs), nebulizers, and soft mist inhalers.
A key driver of market growth is the escalating global prevalence of respiratory illnesses, which has heightened demand for advanced inhalation therapies and effective treatment solutions. Rising healthcare spending, combined with growing awareness of respiratory health, continues to support this expansion. Moreover, deteriorating air quality-caused by factors such as wildfires, vehicular emissions, and industrial activities-has further intensified the reliance on inhalation-based therapies.
Technological advancements, including the use of imaging tools such as fluoroscopy in respiratory care, coupled with ongoing innovations and government-led initiatives to enhance public awareness and access to modern treatment options, are expected to generate significant growth opportunities.
However, market progress may be restrained by high device costs, the presence of alternative treatment options such as oral medications, and insufficient patient awareness regarding proper inhaler usage. Addressing these challenges through targeted educational initiatives and cost-effective product solutions will be critical to improving adoption rates and maximizing clinical outcomes.
Expert Knowledge, Just a Click Away: https://calendly.com/insightaceanalytic/30min?month=2024-02
North America is anticipated to retain a prominent share of the global respiratory inhalers market over the forecast period, supported by rising healthcare expenditure and increasing consumer awareness regarding the availability of over-the-counter inhaler products. The introduction of long-acting and advanced inhalation therapies, underpinned by strong research and development efforts, is expected to further accelerate market growth in the region.
In parallel, the Asia-Pacific respiratory inhalers market is projected to witness significant expansion, driven by a rapidly aging population and growing awareness of respiratory health concerns. Continued improvements in healthcare infrastructure across the region are creating favorable conditions for market development. Moreover, the high incidence of respiratory disorders in Asia-Pacific is fueling demand for effective inhalation therapies, thereby strengthening the region's market outlook.
Major market players operating in the Respiratory Inhalers market include
GlaxoSmithKline, Novartis, Boehringer Ingelheim, Cipla, AstraZeneca, Propeller Health, Beximco Pharmaceuticals (Beximco Pharma), H&T Presspart, Cohero Health, CHIESI Farmaceutici, Mundipharma, 3M, HELTMAN Medikal, Adherium, Luckys Pharma, Amiko Digital Health, Teva Pharmaceutical Industries, Vectura Group, PULMOTREE MEDICAL GmbH, and Vapo Health.
Recent collaborations and agreements in the market:
• In October 2020, Zydus Cadila introduced the country's first pressurized metering dose inhalers for chronic obstructive pulmonary disease patients.
• In July 2020, ProAir® Digihaler® (albuterol sulfate 117 mcg) Inhalation Powder for Patients with Asthma and COPD was introduced by Teva Respiratory, LLC., a U.S. subsidiary of Teva Pharmaceutical Industries Ltd.
Unlock Your GTM Strategy: https://www.insightaceanalytic.com/customisation/1288
Market Segments
Global Respiratory Inhalers Market, by Products, 2022-2030 (Value US$ Mn)
• Metered Dosage
• Dry Powder Inhaler
• Nebulizers
• Compressed Air Nebulizers
• Ultrasonic Nebulizers
• Mesh Nebulizers
Global Respiratory Inhalers Market, by Patient, 2022-2030 (Value US$ Mn)
• Adults
• Pediatric
Global Respiratory Inhalers Market, by Technology, 2022-2030 (Value US$ Mn)
• Manually Operated Inhaler Devices
• Digitally Operated Inhaler Devices
Global Respiratory Inhalers Market, by End-User, 2022-2030 (Value US$ Mn)
• Hospital Pharmacies
• Retail
• Online
Global Respiratory Inhalers Market, by Region, 2022-2030 (Value US$ Mn)
• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa
North America Respiratory Inhalers Market, by Country, 2022-2030 (Value US$ Mn)
• U.S.
• Canada
Europe Respiratory Inhalers Market, by Country, 2022-2030 (Value US$ Mn)
• Germany
• France
• Italy
• Spain
• Russia
• Rest of Europe
Asia Pacific Respiratory Inhalers Market, by Country, 2022-2030 (Value US$ Mn)
• India
• China
• Japan
• South Korea
• Australia & New Zealand
Latin America Respiratory Inhalers Market, by Country, 2022-2030 (Value US$ Mn)
• Brazil
• Mexico
• Rest of Latin America
Middle East & Africa Respiratory Inhalers Market, by Country, 2022-2030 (Value US$ Mn)
• GCC Countries
• South Africa
• Rest of Middle East & Africa
Why should buy this report:
To receive a comprehensive analysis of the prospects for the global Respiratory Inhalers market
To receive an industry overview and future trends in the Respiratory Inhalers market
To analyze the Respiratory Inhalers market drivers and challenges
To get information on the Respiratory Inhalers market value (US$Mn) forecast to 2030
Significant investments, mergers & acquisitions in the Respiratory Inhalers market industry
Read Overview Report- https://www.insightaceanalytic.com/report/global-respiratory-inhalers-market/1288
About Us:
InsightAce Analytic is a market research and consulting firm that enables clients to make strategic decisions. Our qualitative and quantitative market intelligence solutions inform the need for market and competitive intelligence to expand businesses. We help clients gain competitive advantage by identifying untapped markets, exploring new and competing technologies, segmenting potential markets and repositioning products. Our expertise is in providing syndicated and custom market intelligence reports with an in-depth analysis with key market insights in a timely and cost-effective manner.
Contact us:
InsightAce Analytic Pvt. Ltd.
Visit: www.insightaceanalytic.com
Tel : +1 607 400-7072
Asia: +91 79 72967118
info@insightaceanalytic.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Respiratory Inhalers Market Top Companies Study - GlaxoSmithKline, Novartis, Boehringer Ingelheim, Cipla, AstraZeneca. here
News-ID: 4163014 • Views: …
More Releases from Insightace Analytic Pvt Ltd.
Plant Based Bioactive Market Forecast to 2034 with Strong Growth in North Americ …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Plant Based Bioactive Market- by Source (Fruits & vegetables, Plants, Legumes and Others), Application (Flavonoids, Phenolic Acids, Alkaloids, Saponins, Polysaccharides and Others), End-User (Functional Foods & beverages, Dietary Supplements, Animal Nutrition, Personal Care and Others), Trends, Industry Competition Analysis, Revenue and Forecast To 2034."
According to the latest research by InsightAce Analytic, the global Plant Based…
Neoantigen Peptides Manufacturing Market Opportunities Fueled by Biotechnology I …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Neoantigen Peptides Manufacturing Market by Scale of operations (Research/Preclinical, Clinical, Commercial), by End-Users (Pharmaceutical/Vaccine developers companies, Contract Research Organizations (CRO), Academic and Research Institutes)- Trends, Industry Competition Analysis, Revenue and Forecast To 2034."
According to the latest research by InsightAce Analytic, the global Neoantigen Peptides Manufacturing market is expected to grow with CAGR of 16.4%…
Kombucha Market Top Players - Buchi Kombucha, Cell - Nique Corporation, Equinox …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Kombucha Market- by Flavor (Regular/Original, Herbs & Spices, Citrus, Berries, Apple, Coconut & Mangoes, Flowers, and Others), Distribution Channel (Food and Drink Specialty Store, Hypermarket/Supermarket, Convenience Store, and Online Retail), Trends, Industry Competition Analysis, Revenue and Forecast To 2034."
According to the latest research by InsightAce Analytic, the global Kombucha market is valued at US$ 3.27…
Conjugation and Labeling Services Market Current Scenario with Future Aspect Ana …
InsightAce Analytic Pvt. Ltd. announces the release of the market assessment report on "Global Conjugation and Labeling Services Market Size, Share & Trends Analysis Report By Molecules (Proteins, Peptides, Small Molecules, Antibodies, Other Molecules), By Molecular Conjugates/Labels (Polymers, Haptens, Enzymes, Fluorescent Tags, Bead Coupling / Particle Conjugates, Quantum Dots, Isotopes, Other Molecular Conjugates/Labels)- Market Outlook And Industry Analysis 2034"
According to the latest research by InsightAce Analytic, the global Conjugation and…
More Releases for Inhaler
Z!NGHA Introduces Dual-Chamber Aromatherapy Nasal Inhaler
Image: https://www.getnews.info/uploads/e696f4bdf98524eaf4f4f4bc89f2369f.jpg
Miami, FL - December 09, 2024 - Z!NGHA, a new player in the wellness space, is thrilled to announce the launch of its flagship product, the Z!NGHA Double Nasal Inhaler, an innovation that combines the therapeutic benefits of aromatherapy and essential oils with the on-the-go convenience of a dual-chamber nasal inhaler. Unlike the industry standard single chamber nasal inahlers, Z!ngha offers simultaneous inhalation through both nostrils, redefining aromatherapy for…
Asthma Inhaler Device Market By Type (Metered-dose inhaler, MDI with a spacer, D …
The Asthma Inhaler Device Market is expected to grow at a CAGR of 6.42% during the forecast period. The market is also expected to reach a revenue of USD 19677.54 million by the end of 2022-2030. The research report on the market for asthma inhaler devices offers analysis and insights into the numerous aspects that are anticipated to be present over the course of the forecast period as well as…
Increasing Number Of Launches In Generic Version Of Budesonide Inhaler Drive The …
Budesonide is an artificial glucocorticoid steroid related to the naturally-occurring hormone, cortisol or hydrocortisone, which is produced in the adrenal glands. It is used for treating asthma. Budesonide is sold under the brand name Pulmicort. Each budesonide inhaler is designed to provide 60 to 120 inhalations depending on the device. Increasing air population is expected to lead to high prevalence of asthma worldwide. According to World Health Organization (WHO), asthma…
Oxygen Inhaler Market Size, Share, Growth & Forecast 2026
Global Oxygen Inhaler Market report focuses on Oxygen Inhaler volume and value at global level, regional level and company level. From a global perspective, this report represents the overall Oxygen Inhaler market size by analyzing historical data and future prospects. Regionally, this report focuses on several key regions: North America, Europe, China and Japan.
At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for…
Global Digital Dose Inhaler Market Insights, Forecast
Digital Dose Inhaler is a kind of medical instrument. Digital Dose Inhaler enable patients to the number of tracking has consumed doses. The global Digital Dose Inhaler market is valued at 1790 million US$ in 2018 and will reach 3540 million US$ by the end of 2025, growing at a CAGR of 8.9% during 2019-2025. The objectives of this study are to define, segment, and project the size of the…
Dry Powder Inhaler Market Report 2018: Segmentation by Product (Single Dose Dry …
Global Dry Powder Inhaler market research report provides company profile for Astrazeneca Plc., 3M Company, GlaxoSmithKline Plc, Novartis AG, Cipla Ltd., Teva Pharmaceutical Industries Limited, Boehringer Ingelheim GmbH, Chiesi Farmaceutici S.p.A., MannKind Corporation and Others.
This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in terms of volume, revenue, YOY growth rate, and…
